{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Alpha-Synuclein (α-syn) is associated with presynaptic membranes in the brain and is a major constituent of Lewy bodies in Parkinson's disease (PD). Three missense mutations (A30P, A53T, and E46K) in the α-syn gene are associated with rare autosomal dominant forms of familial PD.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states the disease mechanism involving α-syn and its role in PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper uses functional assays to measure lipid changes, which are relevant to the disease mechanism involving α-syn.",
          "judgment": "Yes",
          "reasoning": "The general class of assay (lipid analysis) is applicable to the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper does not explicitly mention controls or replicates for the lipid analysis assays.",
          "judgment": "No",
          "reasoning": "Insufficient information on controls and replicates.",
          "next_step_or_outcome": "Proceed to Sub-step 3b"
        },
        {
          "step_name": "Sub-step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "The lipid analysis methods are broadly accepted in the field.",
          "judgment": "Yes",
          "reasoning": "The assay is a standard technique in the field, implying validation.",
          "next_step_or_outcome": "The functional evidence strength is PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The functional evidence supports the pathogenicity of the SNCA A30P variant, based on the lipid changes observed in the assays, which are relevant to the disease mechanism."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Alpha-Synuclein (α-syn) is associated with presynaptic membranes in the brain and is a major constituent of Lewy bodies in Parkinson's disease (PD). Three missense mutations (A30P, A53T, and E46K) in the α-syn gene are associated with rare autosomal dominant forms of familial PD.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states the disease mechanism involving α-syn and its role in PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper uses functional assays to measure lipid changes, which are relevant to the disease mechanism involving α-syn.",
          "judgment": "Yes",
          "reasoning": "The general class of assay (lipid analysis) is applicable to the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper does not explicitly mention controls or replicates for the lipid analysis assays.",
          "judgment": "No",
          "reasoning": "Insufficient information on controls and replicates.",
          "next_step_or_outcome": "Proceed to Sub-step 3b"
        },
        {
          "step_name": "Sub-step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "The lipid analysis methods are broadly accepted in the field.",
          "judgment": "Yes",
          "reasoning": "The assay is a standard technique in the field, implying validation.",
          "next_step_or_outcome": "The functional evidence strength is PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The functional evidence supports the pathogenicity of the SNCA A53T variant, based on the lipid changes observed in the assays, which are relevant to the disease mechanism."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "E",
          "alt": "K",
          "position": "46"
        },
        "variant_string_id": "SNCA E46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Alpha-Synuclein (α-syn) is associated with presynaptic membranes in the brain and is a major constituent of Lewy bodies in Parkinson's disease (PD). Three missense mutations (A30P, A53T, and E46K) in the α-syn gene are associated with rare autosomal dominant forms of familial PD.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states the disease mechanism involving α-syn and its role in PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper uses functional assays to measure lipid changes, which are relevant to the disease mechanism involving α-syn.",
          "judgment": "Yes",
          "reasoning": "The general class of assay (lipid analysis) is applicable to the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper does not explicitly mention controls or replicates for the lipid analysis assays.",
          "judgment": "No",
          "reasoning": "Insufficient information on controls and replicates.",
          "next_step_or_outcome": "Proceed to Sub-step 3b"
        },
        {
          "step_name": "Sub-step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "The lipid analysis methods are broadly accepted in the field.",
          "judgment": "Yes",
          "reasoning": "The assay is a standard technique in the field, implying validation.",
          "next_step_or_outcome": "The functional evidence strength is PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The functional evidence supports the pathogenicity of the SNCA E46K variant, based on the lipid changes observed in the assays, which are relevant to the disease mechanism."
    }
  ]
}